Word: mckesson
(lookup in dictionary)
(lookup stats)
Dates: during 1960-1969
Sort By: most recent first
(reverse)
...Began Underground. The product's prospects were further heightened last month when Tawn Limited, a subsidiary of McKesson Laboratories, the giant drug wholesaler, bought the production and distribution rights. Until then, Cupid's Quiver was produced by Joseph Laboratories in Los Angeles, a tiny, one-product firm formed this year by Hylton Socher, a public relations man, and Harvey Meyerhoff, a graphics designer. They had acquired the product from Michael Intrator, a musician, who had developed it. For a time, he sold Cupid's Quiver through ads in the Los Angeles Free Press and other underground newspapers...
...build the product's image by selling it through as many prestige outlets as possible and then move it heavily into drugstores. The only loser in this unlikely success story is Marsteller. Tawn executives last week switched the $500,000 account to Kane Light Gladney Inc., which is McKesson's ad agency...
Last winter, armed with testimonials from druggists, the two men contracted with McKesson & Robbins Drug Co. to market the pill counter nationally. Now 1,900 salesmen are distributing leases at $17.50 a month. RX COUNT has already signed 1,724 leases and its revenues are running at an annual rate of almost $362,000-just for openers. Negotiations to produce and lease the counter are going on in Canada, Europe, South Africa and Australia. Rose-berg, now 56, is talking about a model that will also package the pills, type the labels and present a bill to the customer...
...year-old company sold 43,325,000 gallons, partly from springs in the San Bernardino Mountains, partly from five distillation plants and partly from de-ionizing plants, which yield the mineral-free water favored by commercial customers. Runner-up Sparkletts Drinking Water Corp., a subsidiary of Foremost-McKesson, boosted its revenues from $12 million to an estimated $13 million...
Upjohn Co., Kalamazoo, Mich., $1,507,040; Warner-Lambert Pharmaceutical Co., Morris Plains, N.J., $1,500,000; Charles Pfizer & Co., Inc., N.Y.C., $1,500,000; Wyeth Laboratories, Radnor, Pa., $1,491,601; Sterling Drug Inc., N.Y.C., $1,407,076; McKesson & Robbins, Inc., N.Y.C., $1,398,301; Hoffman-La Roche Inc., Nutley, N.J., $1,131,841; Bristol-Myers Co., N.Y.C...